Etanercept


( Last Updated : March 9, 2016)
Generic Name:
Etanercept
Project Status:
Complete
Therapeutic Area:
Rheumatoid arthritis, Ankylosing spondylitis
Manufacturer:
Merck Canada Inc.
Call for patient/clinician input open:
Brand Name:
Brenzys
Project Line:
Reimbursement Review
Project Number:
SE0485-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Biosimilar:
Yes
Submission Type:
Initial
Indications:
Rheumatoid arthritis, ankylosing spondylitis
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: